|
||||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: ENSG00000125386 |
Summary for FAM193A |
Gene summary |
| Gene information | Ensembl ID | ENSG00000125386 | Gene symbol | FAM193A |
| Gene name | family with sequence similarity 193 member A | |
| HGNC | 16822 | |
| Entrez ID | 8603 | |
| Gene type | protein_coding | |
| Synonyms | FAM193A|RES4-22 | |
| UniProtAcc | P78312 |
Drugs associated with this gene(DrugBank). |
| Gene ID | Gene Symbol | Drug ID | Drug Name | Drug Type |
Cancer therapeutic drugs associated with this gene(NCI). |
| Gene ID | Gene Name | Drug ID | Drug Name | Drug Type | Cancer |
Top |
Structure and expression level for FAM193A |
AS events and RNA A-to-I editing events of the gene in TCGA based on Genvode V22 structure.∗For more information on exon skipping events please check the ExonskipDB database. ∗For more information on exon skipping events please check the CAeditome database. |
Landscape of gene expressions across multiple cancer types. |
Differentially expressed gene analysis between tumor male and tumor female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
Differentially expressed gene analysis between tumor male and normal male samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
Differentially expressed gene analysis between tumor female and normal female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
Top |
Sex-biased somatic mutation for FAM193A |
| ∗For more information on exon skipping events please check the ExonskipDB database. |
| Gene ID | Cancer Type | Hugo Symbol | Male | Female | pval | or | ci.up | ci.low | adjPval |
Top |
DNA methylation with beta values for FAM193A |
Landscape of DNA methylation across multiple cancer types. |
Differentially expressed CpG sites between male tumor and female tumor patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
Differentially expressed CpG sites between male tumor and male normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| KIRC | cg05083414 | chr4:2625312 | CGI:chr4:2535371-2537694 | UTR,promoter,exon,gene body | 7.68e-01 | 8.77e-01 | -4.08e+00 | 4.56e-05 | 1.02e-04 | -1.08e-01 |
| LUSC | cg05083414 | chr4:2625312 | CGI:chr4:2535371-2537694 | UTR,promoter,exon,gene body | 6.29e-01 | 7.68e-01 | -2.05e+00 | 4.00e-02 | 4.16e-02 | -1.39e-01 |
| LUSC | cg14853282 | chr4:2624512 | CGI:chr4:2535371-2537694 | promoter | 8.01e-01 | 9.28e-01 | -4.06e+00 | 4.90e-05 | 5.55e-04 | -1.27e-01 |
| LUSC | cg04868219 | chr4:2624529 | CGI:chr4:2535371-2537694 | promoter | 6.24e-01 | 8.56e-01 | -4.41e+00 | 1.02e-05 | 5.26e-04 | -2.32e-01 |
| LUSC | cg05949640 | chr4:2625330 | CGI:chr4:2535371-2537694 | UTR,promoter,exon,gene body | 7.03e-01 | 8.52e-01 | -2.00e+00 | 4.53e-02 | 4.60e-02 | -1.49e-01 |
| LUSC | cg14549256 | chr4:2625415 | CGI:chr4:2535371-2537694 | promoter,gene body | 6.22e-01 | 7.36e-01 | -2.06e+00 | 3.91e-02 | 4.09e-02 | -1.14e-01 |
| LUSC | cg00097088 | chr4:2625519 | CGI:chr4:2535371-2537694 | UTR,promoter,exon,gene body | 7.60e-01 | 9.28e-01 | -4.09e+00 | 4.34e-05 | 5.42e-04 | -1.68e-01 |
Differentially expressed CpG sites between female tumor and female normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| BRCA | cg05083414 | chr4:2625312 | CGI:chr4:2535371-2537694 | UTR,promoter,exon,gene body | 8.23e-01 | 5.27e-01 | 1.42e+01 | 6.49e-46 | 4.40e-43 | 2.96e-01 |
| BRCA | cg25790133 | chr4:2625287 | CGI:chr4:2535371-2537694 | UTR,promoter,exon,gene body | 9.10e-01 | 6.42e-01 | 1.43e+01 | 1.80e-46 | 1.75e-43 | 2.69e-01 |
| BRCA | cg05949640 | chr4:2625330 | CGI:chr4:2535371-2537694 | UTR,promoter,exon,gene body | 8.81e-01 | 6.09e-01 | 1.41e+01 | 4.10e-45 | 1.80e-42 | 2.72e-01 |
| BRCA | cg22980079 | chr4:2625391 | CGI:chr4:2535371-2537694 | UTR,promoter,exon,gene body | 8.75e-01 | 6.59e-01 | 1.42e+01 | 1.39e-45 | 7.80e-43 | 2.16e-01 |
| BRCA | cg14549256 | chr4:2625415 | CGI:chr4:2535371-2537694 | promoter,gene body | 7.95e-01 | 5.18e-01 | 1.43e+01 | 2.26e-46 | 2.02e-43 | 2.77e-01 |
| KIRC | cg05949640 | chr4:2625330 | CGI:chr4:2535371-2537694 | UTR,promoter,exon,gene body | 9.35e-01 | 8.30e-01 | 2.61e+00 | 9.07e-03 | 1.60e-02 | 1.06e-01 |
Top |
Exon skipping events with PSI in TCGA for FAM193A |
| ∗Please access ExonSkipDB for exon skipping annotation. |
Landscape of exon skipping events across multiple cancer types. |
Differentially expressed exon skipping events between male tumor and female tumor patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Differentially expressed exon skipping events between male tumor and male normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Differentially expressed exon skipping events between female tumor and female normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Top |
RNA A-to-I editing events in TCGA for FAM193A |
| ∗Please access CAeditome for RNA editing annotation. |
Landscape of RNA editing events across multiple cancer types. |
Differentially expressed RNA editing events between male tumor and female tumor patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| ESCA | FAM193A-006 | chr4_2725370_+ | 2.68e-01 | 4.78e-01 | -2.79e+00 | 5.27e-03 | 4.99e-02 | -2.10e-01 |
Differentially expressed RNA editing events between male tumor and male normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
Differentially expressed RNA editing events between female tumor and female normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
Protein coding RNA editing(s). |
| Editing Position | Variant Type | Gene Symbol | Transcript ID | NTchange | AAchange |
Top |
Sex-biased TF-Gene network for FAM193A |
TFs related to FAM193A.∗The female-biased TF-gene edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased TF-gene edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
| Cancer Type | TF | Target Gene | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| MESO | ZNF418 | FAM193A | 1.13e+00 | 3.19e-05 | 3.90e+00 | 9.83e-01 | Female-biased |
| READ | ZNF235 | FAM193A | 4.08e+00 | 9.81e-01 | 2.94e+00 | 2.73e-03 | Male-biased |
| THYM | ZNF418 | FAM193A | 3.60e+00 | 8.25e-03 | 4.33e+00 | 9.81e-01 | Female-biased |
FAM193A related gene.∗Only the gene encode TF might with this result. ∗For more information please check Sex-biased TF-Coding gene network. |
Top |
Sex-biased RBP-ES network for FAM193A |
RBPs related to ES in FAM193A.∗The female-biased RBP-ES edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased RBP-ES edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
| Cancer Type | RBP | Target ES | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| ACC | HNRNPH2 | exon_skip_421511 | 7.69e+00 | 2.27e-03 | 8.29e+00 | 9.90e-01 | Female-biased |
| ACC | hnRNPK | exon_skip_421502 | 9.14e+00 | 9.81e-01 | 8.76e+00 | 1.45e-02 | Male-biased |
| UVM | HNRNPH2 | exon_skip_421511 | 7.90e+00 | 6.25e-03 | 8.24e+00 | 9.86e-01 | Female-biased |
| DLBC | HNRNPH2 | exon_skip_421511 | 7.75e+00 | 3.09e-03 | 8.19e+00 | 9.89e-01 | Female-biased |
| LUAD | HNRNPH2 | exon_skip_421511 | 8.01e+00 | 2.91e-03 | 8.47e+00 | 9.90e-01 | Female-biased |
| CHOL | HNRNPH2 | exon_skip_421511 | 8.24e+00 | 1.02e-02 | 8.64e+00 | 9.84e-01 | Female-biased |
| MESO | hnRNPK | exon_skip_421502 | 8.71e+00 | 5.97e-03 | 9.11e+00 | 9.90e-01 | Female-biased |
| GBM | HNRNPH2 | exon_skip_421511 | 8.71e+00 | 9.94e-01 | 7.95e+00 | 1.63e-04 | Male-biased |
| KIRC | HNRNPH2 | exon_skip_421511 | 8.29e+00 | 9.87e-01 | 7.94e+00 | 5.34e-03 | Male-biased |
| KICH | HNRNPH2 | exon_skip_421511 | 7.88e+00 | 1.83e-03 | 8.37e+00 | 9.91e-01 | Female-biased |
| BLCA | HNRNPH2 | exon_skip_421511 | 8.35e+00 | 9.84e-01 | 7.98e+00 | 9.15e-03 | Male-biased |
| SKCM | HNRNPH2 | exon_skip_421511 | 8.10e+00 | 1.08e-02 | 8.45e+00 | 9.83e-01 | Female-biased |
| HNSC | ESRP2 | exon_skip_421497 | 8.67e+00 | 9.85e-01 | 8.32e+00 | 9.59e-03 | Male-biased |
FAM193A related ES.∗Only the gene encode RBP might with this result. ∗For more information please check Sex-biased RBP-ES network in cancer. |
Top |
Sex-biased CeRNA regulation of gene |
Sex-biased CeRNA regulation of gene. |
| Gene ID | ceRNA(lncRNA-miRNA-mRNA) | Group | Cancer Type |
Top |
Sex-biased eQTL regulation of gene |
Sex-biased eQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| eQTL | Description |
Male-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs1838973 | chr4:5155535:G:A | - | 0.133697373720501 | 0.0125682414638498 | LUAD | Female-baised eQTL |
| rs4549382 | chr4:10070844:T:C | - | -0.121646553247658 | 0.03614663659453 | COAD | Female-baised eQTL |
Female-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs1680056 | chr4:1226795:A:C | - | -0.0822331998254741 | 0.030656445090844 | LIHC | Male-baised eQTL |
| rs35376712 | chr4:1229336:A:G | - | -0.0822331998254741 | 0.030656445090844 | LIHC | Male-baised eQTL |
| rs1250118 | chr4:1230258:G:A | - | -0.0822331998254741 | 0.030656445090844 | LIHC | Male-baised eQTL |
| rs4993865 | chr4:1210875:C:T | - | -0.0809523669986585 | 0.0386682323829672 | LIHC | Male-baised eQTL |
| rs1250105 | chr4:1209477:T:C | - | -0.0787017261401379 | 0.0409880881631261 | LIHC | Male-baised eQTL |
| rs1250092 | chr4:1216866:A:G | - | -0.0794828807227923 | 0.0494929281032845 | LIHC | Male-baised eQTL |
| rs6834479 | chr4:12504240:C:G | - | 0.0632936911182379 | 0.0299642905296173 | KIRC | Male-baised eQTL |
| rs6847880 | chr4:12562288:A:G | - | 0.0647774095955709 | 0.0314226021714273 | KIRC | Male-baised eQTL |
| rs13102358 | chr4:481679:T:C | - | -0.0557011949054996 | 0.0332016875023136 | KIRC | Male-baised eQTL |
| rs41362244 | chr4:11765544:T:A | - | 0.0963685875752907 | 0.00525113903126076 | COAD | Male-baised eQTL |
| rs73216289 | chr4:11766128:T:C | - | 0.0963975576677752 | 0.03749415865485 | COAD | Male-baised eQTL |
Opposite sex-biased eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Sex-biased Gene in Cancer | Cancer Type |
Top |
Sex-biased eQTM regulation of gene |
Sex-biased eQTM regulation of gene (The figures only show the pairs with FDR<1e-5. For more information please check the below table). |
| eQTM | Description |
| Gene ID: ENSG00000125386 | |
| CpG Site: cg15913375 | |
| Position to Gene: gene,exon,CDS | |
| Male Effect: -0.340490100258812 | |
| Female Effect: - |
Male-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| cg15913375 | chr4:2695059 | gene,exon,CDS | -0.340490100258812 | 1.88239477480368e-05 | -0.3645874842286596 | 1.0321490532081172e-07 | KIRP |
Female-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
Opposite sex-biased eQTM regulation. |
| CpG Site | CpG Postion | CpG Island | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Male Cor | Male P-value | Female Cor | Female P-value | Sex-biased Coding Gene | Cancer Type |
Top |
Sex-biased sQTL regulation of gene |
Sex-biased sQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTL | Description |
Male-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
Female-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
| exon_skip_421497 | chr4:2689505:2689704 | Frame-shift | rs17132485 | chr4:2369169:C:G | Distant upstream | -0.0267150443398102 | 0.0250027460812538 | LUAD | Male-baised sQTL |
Opposite sex-biased sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Male Effect | Male FDR | Female Effect | Female FDR | Cancer Type |
Top |
Sex-biased sQTM regulation of gene |
Sex-biased sQTM regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTM | Description |
Male-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
Female-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
Opposite sex-biased sQTM regulation. |
| EX ID | EX Info | Skipped Exon | CPG Site | CPG Position | CPG Island | Position to EX Events | Male Effect | Male FDR | Female Effect | Female FDR | Male Correlation | Male P-value | Female Correlation | Female P-value | ORF_anno | Cancer Type |
Top |
Related disease information of FAM193A |
Diseases associated with this gene (DisGeNET). |
| Gene ID | Gene Symbol | Disease ID | Disease Name | Number of PMID | Source |